Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Continuous infusion in haemophilia: current practice in Europe.
Batorova A, Holme P, Gringeri A, Richards M, Hermans C, Altisent C, Lopez-Fernández M, Fijnvandraat K; European Haemophilia Treatment Standardisation Board. Batorova A, et al. Among authors: gringeri a. Haemophilia. 2012 Sep;18(5):753-9. doi: 10.1111/j.1365-2516.2012.02810.x. Epub 2012 Apr 25. Haemophilia. 2012. PMID: 22530687
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
Astermark J, Altisent C, Batorova A, Diniz MJ, Gringeri A, Holme PA, Karafoulidou A, Lopez-Fernández MF, Reipert BM, Rocino A, Schiavoni M, von Depka M, Windyga J, Fijnvandraat K; European Haemophilia Therapy Standardisation Board. Astermark J, et al. Among authors: gringeri a. Haemophilia. 2010 Sep 1;16(5):747-66. doi: 10.1111/j.1365-2516.2010.02231.x. Epub 2010 Apr 14. Haemophilia. 2010. PMID: 20398077 Review.
Special lectures in haemophilia management.
Batorova A, High KA, Gringeri A. Batorova A, et al. Among authors: gringeri a. Haemophilia. 2010 Jul;16 Suppl 5:22-8. doi: 10.1111/j.1365-2516.2010.02289.x. Haemophilia. 2010. PMID: 20590852 Review.
Major challenges of intensive treatment regimens employed today, such a short half life of haemophilia therapeutics with a need for frequent injections and the risk of inhibitor, encourage further development towards the production of factor concentrates with prolon …
Major challenges of intensive treatment regimens employed today, such a short half life of haemophilia therapeutics with a nee …
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement.
Rodriguez-Merchan EC, Rocino A, Ewenstein B, Bartha L, Batorova A, Goudemand J, Gringeri A, Joao-Diniz M, Lopaciuk S, Negrier C, Quintana M, Tagariello G, Tjonnfjord GE, Villar VA, Vorlova Z. Rodriguez-Merchan EC, et al. Among authors: gringeri a. Haemophilia. 2004 Sep;10 Suppl 2:50-2. doi: 10.1111/j.1365-2516.2004.00941.x. Haemophilia. 2004. PMID: 15385047
Pain management in patients with haemophilia: a European survey.
Holstein K, Klamroth R, Richards M, Carvalho M, Pérez-Garrido R, Gringeri A; European Haemophilia Therapy Standardization Board. Holstein K, et al. Among authors: gringeri a. Haemophilia. 2012 Sep;18(5):743-52. doi: 10.1111/j.1365-2516.2012.02808.x. Epub 2012 Apr 25. Haemophilia. 2012. PMID: 22530627 Review.
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement.
Iorio A, Iserman E, Blanchette V, Dolan G, Escuriola Ettingshausen C, Hermans C, Negrier C, Oldenburg J, Reininger A, Rodriguez-Merchan C, Spannagl M, Valentino LA, Young G, Steinitz-Trost KN, Gringeri A. Iorio A, et al. Among authors: gringeri a. Haemophilia. 2017 May;23(3):e170-e179. doi: 10.1111/hae.13215. Epub 2017 Mar 26. Haemophilia. 2017. PMID: 28345268
Haemophilia care in Europe: the ESCHQoL study.
Schramm W, Gringeri A, Ljung R, Berger K, Crispin A, Bullinger M, Giangrande PL, Von Mackensen S, Mantovani LG, Nemes L, Serban M; ESCHQOL Study Group. Schramm W, et al. Among authors: gringeri a. Haemophilia. 2012 Sep;18(5):729-37. doi: 10.1111/j.1365-2516.2012.02847.x. Epub 2012 May 29. Haemophilia. 2012. PMID: 22639833
191 results